3 Diabetes Biotechs That Could Surge 50% or More in 2018 Post author:Sam Post published:January 21, 2018 Post category:BioPharma Wall Street projects these three biotechs will grow the fastest over the next 12 months. Source: BioSpace You Might Also Like Teva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital January 31, 2018 Former GlaxoSmithKline CEO and R&D Boss Secure New Gigs at Biotech VC Firms September 18, 2017 Bridging Clinical Research & Clinical Health Care: How to Improve Patient Centricity January 8, 2018
